REQUEST A DEMO
Total
USD $0.00
Search more companies

Gammamedica Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Electronic Shopping and Mail-Order Houses
Full name: Gammamedica Sp. z o.o. Profile Updated: June 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Gammamedica Sp. z o.o. is a company in Poland, with a head office in Krakow. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on March 12, 2019. There was a net sales revenue increase of 102.74% reported in Gammamedica Sp. z o.o.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 104.83%.

Headquarters
Ul. Malborska 130
Krakow; Malopolskie; Postal Code: 30-624

Contact Details: Purchase the Gammamedica Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gammamedica Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Gammamedica Sp. z o.o. report to view the information.
Incorporation Date:
March 12, 2019
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Subsidiaries
Reha-Bud Sp. z o.o.
100%
Integratormedyczny.Pl
50%
Company Performance
Financial values in the chart are available after Gammamedica Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
102.74%
Total operating revenue
103.89%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
104.83%
Total equity
111.16%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
32.44%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?